chr7-66087368-C-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000048.4(ASL):c.637C>T(p.Arg213*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000151 in 1,454,716 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 31)
Exomes 𝑓: 0.000015 ( 0 hom. )
Consequence
ASL
NM_000048.4 stop_gained
NM_000048.4 stop_gained
Scores
2
4
1
Clinical Significance
Conservation
PhyloP100: 2.61
Genes affected
ASL (HGNC:746): (argininosuccinate lyase) This gene encodes a member of the lyase 1 family. The encoded protein forms a cytosolic homotetramer and primarily catalyzes the reversible hydrolytic cleavage of argininosuccinate into arginine and fumarate, an essential step in the liver in detoxifying ammonia via the urea cycle. Mutations in this gene result in the autosomal recessive disorder argininosuccinic aciduria, or argininosuccinic acid lyase deficiency. A nontranscribed pseudogene is also located on the long arm of chromosome 22. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 7-66087368-C-T is Pathogenic according to our data. Variant chr7-66087368-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 426366.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASL | NM_000048.4 | c.637C>T | p.Arg213* | stop_gained | 9/17 | ENST00000304874.14 | NP_000039.2 | |
ASL | NM_001024943.2 | c.637C>T | p.Arg213* | stop_gained | 8/16 | NP_001020114.1 | ||
ASL | NM_001024944.2 | c.637C>T | p.Arg213* | stop_gained | 8/15 | NP_001020115.1 | ||
ASL | NM_001024946.2 | c.559C>T | p.Arg187* | stop_gained | 7/15 | NP_001020117.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASL | ENST00000304874.14 | c.637C>T | p.Arg213* | stop_gained | 9/17 | 1 | NM_000048.4 | ENSP00000307188.9 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD3 exomes AF: 0.0000204 AC: 5AN: 245196Hom.: 0 AF XY: 0.0000300 AC XY: 4AN XY: 133254
GnomAD3 exomes
AF:
AC:
5
AN:
245196
Hom.:
AF XY:
AC XY:
4
AN XY:
133254
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1454716Hom.: 0 Cov.: 35 AF XY: 0.0000124 AC XY: 9AN XY: 724014
GnomAD4 exome
AF:
AC:
22
AN:
1454716
Hom.:
Cov.:
35
AF XY:
AC XY:
9
AN XY:
724014
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ExAC
AF:
AC:
1
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Argininosuccinate lyase deficiency Pathogenic:7
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Dec 15, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jan 05, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 13, 2023 | This sequence change creates a premature translational stop signal (p.Arg213*) in the ASL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ASL are known to be pathogenic (PMID: 2263616, 24166829). This variant is present in population databases (rs761651320, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with argininosuccinate lyase deficiency (PMID: 17326097, 30285816, 31183366). ClinVar contains an entry for this variant (Variation ID: 426366). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 03, 2017 | Variant summary: The ASL c.637C>T (p.Arg213X) variant results in a premature termination codon, predicted to cause a truncated or absent ASL protein due to nonsense mediated decay, which are commonly known mechanisms for disease. This variant was found in 1/118802 control chromosomes at a frequency of 0.0000084, which does not exceed the estimated maximal expected allele frequency of a pathogenic ASL variant (0.0042258). Multiple publications have cited the variant in affected compound heterozygotes and homozygote individuals. In addition, multiple clinical diagnostic laboratories classified this variant as pathogenic. Taken together, this variant is classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Aug 01, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Feb 13, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jul 16, 2021 | The ASL c.637C>T (p.Arg213Ter) variant is a stop-gained variant that is predicted to result in a premature termination or absence of the protein. The p.Arg213Ter variant is reported in at least eight individuals with argininosuccinate lyase deficiency, including in a homozygous state in one individual and in a compound heterozygous state, most often with a missense variant, in at least seven individuals (Trevisson et al. 2007; Balmer et al. 2014; Bijarnia-Mahay et al. 2018; Zhao et al. 2019; Zhang et al. 2021; Kido et al. 2021). Commonly reported phenotypic features in these individuals included hyperammonemia, elevated argininosuccinic acid, intellectual disability, epilepsy, and hepatic disease. The p.Arg213Ter variant is reported at a frequency of 0.000163 in the South Asian population of the Genome Aggregation Database (version 2.1.1). Transfection of the ASL p.Arg213Ter variant into HEK293T cells resulted in a significantly reduced enzyme activity as compared to cells transfected with the wild type protein (Zhao et al. 2019). Based on the available evidence, the p.Arg213Ter variant is classified as pathogenic for argininosuccinate lyase deficiency. - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Aug 08, 2018 | The R213X variant has been reported previously in association with argininosuccinic aciduria (Trevisson et al. 2007). The R213X variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The R213X variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. In summary, we interpret this variant as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 30, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
Vest4
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: 18
Find out detailed SpliceAI scores and Pangolin per-transcript scores at